LPA and prostate cancer: Multivariable MR using the cis-variant for Lp(a) adjusting for LDL-c levels provided strong evidence for genetically proxied Lp(a) on lower prostate cancer risk (OR = 1.05, 95% CI = 1.01 to 1.08, P = 0.013).